Diagnosis and management of pulmonary vasculitis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 6, p. 375, doi. 10.1177/1753465812454693
- By:
- Publication type:
- Article
Works matching IS 17534658 AND DT 2012 AND VI 6 AND IP 6
Results: 6
1
2
Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 6, p. 363, doi. 10.1177/1753465812459899
- By:
- Publication type:
- Article
3
Impact of prior systemic corticosteroid use in patients admitted with community-acquired pneumonia.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 6, p. 323, doi. 10.1177/1753465812458985
- By:
- Publication type:
- Article
4
Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 6, p. 315, doi. 10.1177/1753465812458984
- By:
- Publication type:
- Article
5
An update on the use of ambrisentan in pulmonary arterial hypertension.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 6, p. 331, doi. 10.1177/1753465812458014
- By:
- Publication type:
- Article
6
The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2012, v. 6, n. 6, p. 345, doi. 10.1177/1753465812463626
- By:
- Publication type:
- Article